Here we have characterized the contribution of dysferlin-deficiency to the pathology of dystroglycanopathy using double mutant mice for dysferlin and α-DG glycosylation. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.